Bullboard - Stock Discussion Forum Entero Therapeutics Inc ENTO

Healthcare Biotechnology

Entero Therapeutics, Inc., formerly First Wave BioPharma, Inc., is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. Its programs address unmet needs in GI health and include latiglutenase, a Phase III-ready, oral biotherapeutic designed to aid gluten digestion and potentially reduce symptoms of... see more

Add To Watchlist

Bullboard (NDAQ:ENTO)

View:

Post by Iseneschalon Jun 13, 2023 12:47pm

FWBI.... 70 million shs have traded ... WTF...up a buck?

Give me a break

Post by Iseneschalon Jun 13, 2023 12:13pm

FWBI ....all this volume can only mean 1 thing ; )

sec.gov/Archives/edgar/data/1604191/000110465923067826/tm2317619d1_s1.htm

Post by Iseneschalon Jun 13, 2023 10:18am

FWBI ... my old nemesis ...back from the dead ; )

In PB mode at $2.40 Might be done for the day

Post by whytestockson Jun 13, 2023 10:00am

CPI Report Live: May Inflation Report Is Out, Here's What It

Just In: $FWBI CPI Report Live: May Inflation Report Is Out, Here's What It Shows2023-06-13 08:29:54 ET In this year@s fast-paced financial markets, research reigns supreme for investors seeking ...more

(0)
•••

Post by PressReleaseon Mar 13, 2023 8:00am

New Press Release - First Wave BioPharma Announces $4.0 Million Private Placement Priced At-The-Market under Nasdaq Rules

BOCA RATON, Fla., March 13, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc. ("First Wave BioPharma" or the “Company”) (NASDAQ: FWBI), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, today...read article.

(0)
•••

Post by PressReleaseon Mar 13, 2023 7:00am

New Press Release - HOOKIPA Pharma Appoints Terry Coelho to its Board of Directors

NEW YORK and VIENNA, March 13, 2023 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, announced today that Terry Coelho will join its Board of Directors, Audit Committee and...read article.

(0)
•••

Post by PressReleaseon Mar 10, 2023 7:00am

New Press Release - First Wave BioPharma Announces Second Patient Dosed in Phase 2 SPAN Clinical Trial of Enhanced Adrulipase Formulation in Cystic Fibrosis

Three U.S. clinical trial sites actively screening and enrolling patients; Topline data expected by mid-2023 BOCA RATON, Fla., March 10, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc. (NASDAQ:FWBI) (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company...read article.

(0)
•••

Post by PressReleaseon Mar 09, 2023 7:00am

New Press Release - First Wave BioPharma Announces First Patient Dosed in Phase 2 SPAN Clinical Trial of Enhanced Adrulipase Formulation

Topline data anticipated by mid-2023 BOCA RATON, Fla., March 09, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc. (NASDAQ:FWBI) (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for...read article.

(0)
•••

Post by PressReleaseon Feb 28, 2023 7:00am

New Press Release - First Wave BioPharma to Participate in 'Fireside Chat' at the 35th Annual Roth Conference

BOCA RATON, Fla., Feb. 28, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc. (NASDAQ:FWBI) (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, announced...read article.

(0)
•••

Post by PressReleaseon Feb 21, 2023 7:00am

New Press Release - First Wave BioPharma Announces Phase 2 Adrulipase Combination Trial Data to be Presented at the 2023 Digestive Disease Week (DDW) Conference

Presentation to highlight clinical results examining adrulipase in combination with porcine pancreatic enzyme replacement therapy (PERT) as a treatment for severe exocrine pancreatic insufficiency (EPI) in patients with cystic fibrosis (CF) BOCA RATON, Fla., Feb. 21, 2023 (GLOBE NEWSWIRE...read article.

Comment by Iseneschalon Feb 17, 2023 12:06pm

RE:FWBI ..... small add this a.m

Hey Mr. M.......you're supposed to move the share price down after I buy.....oh ...you did LoL.....now I'm in the green with a small position I'm patient......I know you by now ; ) Does ...more